Recurrent hepatitis C: The bane of transplant hepatology
Potential conflict of interest: Dr. Te has received grants and done research for AbbVie and is on the advisory board of Gilead Sciences. She consults for Gilead, Idenix, and Astellas.
See Article on Page 35
No abstract is available for this article.